CONSOLIDATION THERAPY WITH INTERMEDIATE-DOSE METHOTREXATE (IDM) ALONE, OR IDM AND L-ASPARAGINASE (ASP), OR IDM AND CYTOSINE-ARABINOSIDE (ARAC) IN STANDARD RISK ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) OF CHILDHOOD -A PEDIATRIC-ONCOLOGY-GROUP (POG) STUDY
Mb. Harris et al., CONSOLIDATION THERAPY WITH INTERMEDIATE-DOSE METHOTREXATE (IDM) ALONE, OR IDM AND L-ASPARAGINASE (ASP), OR IDM AND CYTOSINE-ARABINOSIDE (ARAC) IN STANDARD RISK ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) OF CHILDHOOD -A PEDIATRIC-ONCOLOGY-GROUP (POG) STUDY, Blood, 88(10), 1996, pp. 2661-2661